Detalhe da pesquisa
1.
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
Gastroenterology
; 145(5): 1035-1044.e5, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23924660
2.
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.
Hepatology
; 57(3): 974-84, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23081753
3.
Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis.
J Hepatol
; 58(3): 479-87, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23183529
4.
Factors that predict response of patients with hepatitis C virus infection to boceprevir.
Gastroenterology
; 143(3): 608-618.e5, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22626609
5.
Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection.
Clin Gastroenterol Hepatol
; 11(1): 81-87.e4; quiz e5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23064222
6.
Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin.
Hepatology
; 56(2): 567-75, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22619063
7.
The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections.
Pediatr Infect Dis J
; 42(3): 199-205, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476623
8.
Unsuspected Toxoplasma gondii empyema in a bone marrow transplant recipient.
Clin Infect Dis
; 34(9): e37-9, 2002 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11941570